简体中文 | 繁體中文 | English

Health and Pharmaceutical Press Releases

2025-12-11 14:43 Galderma Announces First Patient Enrollment in Study to Assess Nemolizumab in Adults With Chronic Pruritus of Unknown Origin
2025-12-11 14:07 Cleveland Clinic Neurological Institute and Baszucki Group Team Up to Advance Landmark Brain Study with Metabolic Health Markers
2025-12-11 14:02 Polpharma Biologics and Libbs Farmacêutica Sign Licensing Agreement for a Biosimilar for Autoimmune Diseases
2025-12-11 13:43 Biocytogen Completes STAR Market IPO, Becoming the First “H+A” Global Drug Innovator
2025-12-10 14:51 SoluPet Inc. (SoluPet) Announces Strategic Partnership with CHC Healthcare Group (CHC) to Advance Canine Cognitive Health in Asia
2025-12-09 16:35 iFIT and F45 Training Announce Global Partnership to Bridge Digital and Studio Fitness
2025-12-09 15:42 BRUKINSA Delivers Landmark 74% 6-Year PFS in Patients with Treatment-Naïve Chronic Lymphocytic Leukemia
2025-12-09 15:37 Sonrotoclax Data at ASH 2025 Confirm Foundational Potential Across B-cell Malignancies
2025-12-08 15:31 Hemato-Oncology Trials: AOP Health Presents New Results at Top Congress ASH
2025-12-08 14:51 Galderma Welcomes Increased Equity Investment From L’Oréal
2025-12-08 11:26 Protagonist and Takeda Present Longer-Term Data at ASH 2025 Showing Rusfertide Delivers Durable Response and Hematocrit Control in Polycythemia Vera
2025-12-08 10:51 Arthur D. Little and Vega IT Unveil Joint Venture for Digital Innovation
2025-12-05 16:53 Parse Biosciences Launches Evercode Whole Blood Fixation
2025-12-05 16:37 IDE034, a Bispecific ADC Licensed by Biocytogen to IDEAYA, Receives FDA IND Clearance
2025-12-05 14:48 Galderma Opens up New Chapter for Sculptra® with MDR Certification and New Expanded Indication for Body
2025-12-05 10:41 University of Maryland Launches Innovative Clinician Training Program in Ketogenic Metabolic Therapy for Mental Health
2025-12-05 09:59 Galderma Secures ‘BBB’ Credit Rating With Positive Outlook from S&P Global Ratings
2025-11-27 10:05 U.S. FDA Grants Priority Review to Sonrotoclax for the Treatment of Relapsed or Refractory Mantle Cell Lymphoma
2025-11-26 15:12 With Two in Five Employees Undergoing Fertility Treatment Leaving Their Jobs or Considering Quitting, Are Companies Doing Enough?
2025-11-26 15:08 Celltrion Announces European Commission Approval of Additional Line Extension for Omlyclo™ 300mg

Business Wire Weibo

Press Releases

Latest Releases